Review for 'Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L'

Autor:	Michael E. Trautmann
Rok vydání:	2019
Předmět:	medicine.medical_specialty Multicenter study business.industry Internal medicine medicine Type 2 Diabetes Mellitus Open label business Fixed ratio Insulin Glargine / Lixisenatide
DOI:	10.1111/dom.14036/v1/review2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0ce90a82fc90730139a79c321a776398 https://doi.org/10.1111/dom.14036/v1/review2 Zobrazit plný text záznamu